Certified by Founder Lodge
Oxford Science Enterprises
United Kingdom - Oxford, England
INVESTOR
1 Disclosed Funding Rounds $85,000,000
48 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational businesses via our unique partnership with the
| Company | Date | Round | Raised |
|---|---|---|---|
 Mixergy Ltd |
March, 28 ,2023 | Unknown | $11,326,000 |
 BibliU |
June, 09 ,2022 | Series B | $15,000,000 |
 Osler Diagnostics |
November, 07 ,2022 | Series C | $85,000,000 |
 Caristo Diagnostics |
April, 18 ,2023 | Series A | $16,300,000 |
 Oxford Ionics |
January, 12 ,2023 | Series A | $36,500,000 |
 PQShield |
January, 26 ,2022 | Series A | $20,000,000 |
 Salience Labs |
May, 12 ,2022 | Seed | $11,500,000 |
 Prolific |
July, 14 ,2023 | Unknown | $32,764,500 |
| BibliU |
June, 09 ,2022 | Series B | $15,000,000 |
| Mixergy Ltd |
March, 28 ,2023 | Unknown | $11,326,000 |
| Caristo Diagnostics |
April, 18 ,2023 | Series A | $16,300,000 |
| Salience Labs |
May, 12 ,2022 | Seed | $11,500,000 |
 AlveoGene |
September, 15 ,2023 | Seed | |
| PQShield |
January, 26 ,2022 | Series A | $20,000,000 |
| Prolific |
July, 14 ,2023 | Unknown | $32,764,500 |
| Mixergy Ltd |
March, 28 ,2023 | Unknown | $11,326,000 |
 Navenio |
September, 21 ,2023 | Unknown | $6,300,000 |
| Caristo Diagnostics |
April, 18 ,2023 | Series A | $16,300,000 |
| AlveoGene |
September, 15 ,2023 | Seed | |
| PQShield |
January, 26 ,2022 | Series A | $20,000,000 |
 Sitryx |
September, 28 ,2023 | Unknown | $39,500,000 |
| Prolific |
July, 14 ,2023 | Unknown | $32,764,500 |
| Navenio |
September, 21 ,2023 | Unknown | $6,300,000 |
| Caristo Diagnostics |
April, 18 ,2023 | Series A | $16,300,000 |
 Oxford Quantum Circuits |
November, 28 ,2023 | Unknown | $100,000,000 |
| AlveoGene |
September, 15 ,2023 | Seed | |
| Sitryx |
September, 28 ,2023 | Unknown | $39,500,000 |
| Prolific |
July, 14 ,2023 | Unknown | $32,764,500 |
 Grey Wolf Therapeutics |
May, 23 ,2024 | Series B | $50,000,000 |
| Navenio |
September, 21 ,2023 | Unknown | $6,300,000 |
| Oxford Quantum Circuits |
November, 28 ,2023 | Unknown | $100,000,000 |
| AlveoGene |
September, 15 ,2023 | Seed | |
 Beacon Therapeutics |
July, 10 ,2024 | Series B | $170,000,000 |
| Sitryx |
September, 28 ,2023 | Unknown | $39,500,000 |
| Grey Wolf Therapeutics |
May, 23 ,2024 | Series B | $50,000,000 |
| Navenio |
September, 21 ,2023 | Unknown | $6,300,000 |
| Oxford Quantum Circuits |
November, 28 ,2023 | Unknown | $100,000,000 |
| Beacon Therapeutics |
July, 10 ,2024 | Series B | $170,000,000 |
| Sitryx |
September, 28 ,2023 | Unknown | $39,500,000 |
 Fractile |
July, 26 ,2024 | Seed | $15,000,000 |
| Grey Wolf Therapeutics |
May, 23 ,2024 | Series B | $50,000,000 |
 Alloyed |
March, 18 ,2025 | Series B | $47,989,925 |
| Oxford Quantum Circuits |
November, 28 ,2023 | Unknown | $100,000,000 |
| Beacon Therapeutics |
July, 10 ,2024 | Series B | $170,000,000 |
| Grey Wolf Therapeutics |
May, 23 ,2024 | Series B | $50,000,000 |
| Beacon Therapeutics |
July, 10 ,2024 | Series B | $170,000,000 |
| Fractile |
July, 26 ,2024 | Seed | $15,000,000 |
| Alloyed |
March, 18 ,2025 | Series B | $47,989,925 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Brellium | $13,700,000 | (Apr 22, 2025)
Terra Security | $7,500,000 | (Apr 22, 2025)
CSignum | $8,021,670 | (Apr 22, 2025)
ROH | $9,000,000 | (Apr 22, 2025)
GoldState Music | $500,000,000 | (Apr 22, 2025)
